H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Go back to H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 103.00 +4.34 (4.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.66 | 52 Week High | $18.39 | |||
| Open | $98.86 | 52 Week Low | $6.96 | |||
| Day High | $104.09 | P/E | N/A | |||
| Day Low | $98.58 | EPS | $-0.58 | |||
| Volume | 2,199,506 | |||||

